Ulcecur en es it fr

Ulcecur Brand names, Ulcecur Analogs

Ulcecur Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ulcecur Chemical_Formula


Ulcecur RX_link


Ulcecur fda sheet

Ulcecur FDA

Ulcecur msds (material safety sheet)

Ulcecur MSDS

Ulcecur Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ulcecur Molecular Weight

314.405 g/mol

Ulcecur Melting Point

69-70 oC

Ulcecur H2O Solubility

24.7 mg/mL

Ulcecur State


Ulcecur LogP


Ulcecur Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ulcecur Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ulcecur Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ulcecur Absorption

Approximately 50% bioavailability orally.

Ulcecur side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ulcecur Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ulcecur Organisms Affected

Humans and other mammals